|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.42 HKD | +4.46% |
|
-3.78% | -32.93% |
| 06-25 | CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Argentina | MT |
| 06-25 | Cansino Biologics Inc. Obtains Drug Registration Certificate for Mcv4 in Argentina | CI |
| Market Cap | 8.55B 9.91B 1.26B 1.11B 1.02B 945M 1.79B 121B 1.82B 12.23B 4.79B 59.56B 4.74B 4.64B 204B | P/E 2026 * |
34.1x | P/E 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.47B 9.81B 1.25B 1.1B 1.01B 935M 1.77B 119B 1.8B 12.11B 4.75B 58.97B 4.7B 4.6B 202B | EV / Sales 2026 * |
5.93x | EV / Sales 2027 * | 4.44x |
| Free-Float |
39.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +4.46% | ||
| 1 week | -3.78% | ||
| Current month | +5.12% | ||
| 1 month | +1.21% | ||
| 3 months | -28.47% | ||
| 6 months | -38.37% | ||
| Current year | -32.93% |
| 1 week | 22 |  | 25.02 |
| 1 month | 19.22 | | 25.02 |
| Current year | 19.22 | | 41.64 |
| 1 year | 19.22 | | 56.55 |
| 3 years | 14.8 | | 56.55 |
| 5 years | 14.8 | | 398 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 2009-01-12 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 2009-01-12 |
Xue Feng Yu
CEO | Chief Executive Officer | 62 | 2009-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Shou Bai Chao
BRD | Director/Board Member | 63 | 2018-06-21 |
Xue Feng Yu
CHM | Chairman | 62 | 2009-01-12 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 2021-05-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-08-25 | Sell | Director | 4,600 | 0.0069% | ||
| 24-09-25 | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 24-09-08 | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.46% | -3.78% | -34.49% | -11.46% | 1.26B | |
| -0.51% | +1.57% | +18.72% | -5.52% | 67.61B | |
| -5.16% | -8.63% | +37.37% | +202.27% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 40.94B | |
| +0.12% | -7.85% | +47.16% | -29.27% | 29.4B | |
| -10.83% | -14.41% | +99.15% | -44.54% | 27.09B | |
| -1.53% | -0.13% | +65.92% | +88.58% | 23.32B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.89B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 16.91B | |
| Average | -0.80% | -3.10% | +29.68% | +51.84% | 32.1B | |
| Weighted average by Cap. | -1.34% | -2.84% | +30.24% | +49.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.43B 1.65B 211M 185M 171M 158M 299M 20.12B 304M 2.04B 800M 9.94B 792M 775M 34.11B | 1.79B 2.08B 265M 233M 215M 198M 376M 25.28B 381M 2.57B 1.01B 12.49B 995M 974M 42.86B |
| Net income | 144M 167M 21.34M 18.73M 17.27M 15.95M 30.25M 2.03B 30.7M 206M 80.92M 1.01B 80.11M 78.37M 3.45B | 395M 458M 58.38M 51.23M 47.26M 43.64M 82.77M 5.57B 84M 565M 221M 2.75B 219M 214M 9.44B |
| Net Debt | -85.1M -98.59M -12.58M -11.04M -10.18M -9.4M -17.83M -1.2B -18.1M -122M -47.69M -593M -47.22M -46.19M -2.03B | -581M -673M -85.81M -75.3M -69.46M -64.13M -122M -8.18B -123M -830M -325M -4.04B -322M -315M -13.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | HK$23.42 | +4.46% | 666,200 |
| 26-07-09 | HK$22.42 | -2.27% | 504,200 |
| 26-07-08 | HK$22.94 | -0.78% | 364,299 |
| 26-07-07 | HK$23.12 | -3.67% | 401,400 |
| 26-07-06 | HK$24.00 | -1.40% | 677,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
